Literature DB >> 6384782

Pulmonary epithelial permeability in hyaline-membrane disease.

A L Jefferies, G Coates, H O'Brodovich.   

Abstract

Neonatal hyaline-membrane disease is complicated by pulmonary edema, yet left atrial pressures are normal. Alveolar-capillary-membrane permeability may therefore be increased. To assess pulmonary epithelial permeability, we measured the pulmonary clearance and half-life of aerosolized 99mTc-diethylenetriamine pentacetate (99mTc-DTPA) on 31 occasions in 15 intubated premature infants with hyaline-membrane disease. Three infants with respiratory failure due to other diseases were studied on four occasions. All studies of infants with hyaline-membrane disease that were performed in the first 72 hours of life demonstrated a biphasic clearance curve with a rapid-phase half-life of 1.6 +/- 0.6 minutes (mean +/- S.D.). As these infants recovered, the curve became monophasic with a half-life of 56.0 +/- 32.1 minutes. Two infants remained dependent on oxygen and ventilator support and had persistent biphasic curves with a rapid-phase half-life of 1.5 +/- 0.7 minutes. All infants without hyaline-membrane disease had monophasic curves with a half-life of 65.4 +/- 33.6 minutes. Using a similar technique, we observed that newborn lambs and piglets have a monophasic pulmonary clearance of 99mTc-DTPA (114 +/- 59 minutes in lambs and 52.5 +/- 16.3 minutes in piglets). We conclude that the lungs of neonates with hyaline-membrane disease are abnormally permeable to small solutes and that this abnormality persists in infants with subsequent chronic lung disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6384782     DOI: 10.1056/NEJM198410253111703

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  21 in total

1.  Measurement of protein flux with positron emission tomography in neonates.

Authors:  V Nama; J K Kozlowski; A Hamvas
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-01       Impact factor: 5.747

Review 2.  Diuretics for respiratory distress syndrome in preterm infants.

Authors:  Audra Stewart; Luc P Brion; Roger Soll
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

Review 3.  A risk-benefit assessment of drugs used for neonatal chronic lung disease.

Authors:  D G Sweet; H L Halliday
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

Review 4.  The use of radionuclide techniques in the assessment of alveolar-capillary membrane permeability on the intensive care unit.

Authors:  D N Hunter; C J Morgan; T W Evans
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

Review 5.  Inflammatory mediators in the immunobiology of bronchopulmonary dysplasia.

Authors:  Rita M Ryan; Qadeer Ahmed; Satyan Lakshminrusimha
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

6.  Clara cell secretory protein (CC16) as a peripheral blood biomarker of lung injury in ventilated preterm neonates.

Authors:  Kosmas Sarafidis; Theodora Stathopoulou; Elisavet Diamanti; Vasiliki Soubasi; Charalambos Agakidis; Aikaterini Balaska; Vasiliki Drossou
Journal:  Eur J Pediatr       Date:  2008-06-03       Impact factor: 3.183

Review 7.  Pulmonary clearance of 99mTc-DTPA: a noninvasive assessment of epithelial integrity.

Authors:  H O'Brodovich; G Coates
Journal:  Lung       Date:  1987       Impact factor: 2.584

Review 8.  Solute permeability of the alveolar capillary barrier.

Authors:  M P Barrowcliffe; J G Jones
Journal:  Thorax       Date:  1987-01       Impact factor: 9.139

9.  Pulmonary clearance of technetium 99m diethylene triamine penta-acetic acid aerosol in patients with amiodarone pneumonitis.

Authors:  M Terra-Filho; F S Vargas; J C Meneguetti; J Soares Júnior; A Cukier; L R Teixeira; E E Camargo
Journal:  Eur J Nucl Med       Date:  1990

10.  Alveolar permeability in HIV antibody positive patients with Pneumocystis carinii pneumonia.

Authors:  M J O'Doherty; C J Page; C S Bradbeer; M Shahmanesh; A Edwards; D Barlow; N T Bateman; D N Croft
Journal:  Genitourin Med       Date:  1987-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.